Acrivon Therapeutics, Inc.
ACRV
$1.62
$0.095.88%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -4.25% | 3.83% | 64.16% | -13.72% | -10.30% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 40.37% | -15.93% | -16.01% | -2.95% | -6.99% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -3.89% | 3.63% | 62.61% | -13.53% | -10.24% |
|
|||||
Total Current Assets | -3.89% | 3.63% | 62.61% | -13.53% | -10.24% |
Net Property, Plant & Equipment | -5.22% | 13.76% | -2.23% | -3.73% | 27.78% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.11% | 107.31% | 16.21% | 15.04% | 61.80% |
Total Assets | -8.43% | -6.90% | 91.32% | -12.83% | -8.49% |
|
|||||
Total Accounts Payable | -49.67% | 19.43% | -38.67% | -59.27% | 235.64% |
Total Accrued Expenses | 25.47% | 40.07% | 48.58% | -20.07% | 5.11% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.63% | 6.34% | 3.60% | 7.64% | 13.02% |
Total Finance Division Other Current Liabilities | -- | -- | 96.53% | -- | -- |
Total Other Current Liabilities | -- | -- | 96.53% | -- | -- |
Total Current Liabilities | 16.16% | 31.33% | 24.81% | -32.04% | 43.06% |
|
|||||
Total Current Liabilities | 16.16% | 31.33% | 24.81% | -32.04% | 43.06% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -12.95% | -8.33% | -7.37% | -7.06% | 3.38% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 11.30% | 22.48% | 15.83% | -26.53% | 31.89% |
|
|||||
Common Stock & APIC | 0.83% | 0.67% | 52.63% | 1.37% | 0.88% |
Retained Earnings | -13.11% | -14.79% | -14.14% | -14.16% | -19.81% |
Treasury Stock & Other | -42.84% | 4,215.79% | 72.86% | 15.66% | 72.52% |
Total Common Equity | -10.21% | -8.87% | 100.09% | -10.90% | -12.27% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -10.21% | -8.87% | 100.09% | -10.90% | -12.27% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -10.21% | -8.87% | 100.09% | -10.90% | -12.27% |
|